Loading stock data…
KMTS
$21.82+1.10 (+5.31%)
Market ClosedLast close May 1
Kestra Medical Technologies, Ltd.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Kestra Medical Technologies, Ltd. in the Healthcare sector is trading at $21.82. The stock is currently 27% below its 52-week high of $30.00, remaining 3.5% below its 200-day moving average. Technical signals show neutral RSI of 63 and bullish MACD crossover, explaining why KMTS maintains its current current market pressure. The Whystock Score of 50/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Neutral momentum (RSI 63) — price action in range
Long-term trend bearish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$21.82
Potential Upside
5%
Whystock Fair Value$22.91
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Fundamentals
Kestra Medical Technologies, Ltd. operates as a wearable medical device and digital healthcare company. It focuses on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitiv...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$1.33B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-50.29%
Volume
Today's trading volume
167,607
Recent News
Assessing Kestra Medical Technologies (KMTS) Valuation After Recent Share Price Weakness
Kestra Medical Technologies (KMTS) has drawn investor attention after recent trading left the stock about 23% lower over the past month and roughly 28% lower over the past 3 months. See our latest analysis for Kestra Medical Technologies. With the share price at US$19.46, the stock has a 7 day share price return of 1.9%. However, the 30 day and year to date share price returns of about 23% and 20% declines point to fading short term momentum, despite a 1 year total shareholder return of...
Kestra Medical Technologies Q3 Earnings Call Highlights
Kestra Medical Technologies (NASDAQ:KMTS) reported what management described as a strong third quarter of fiscal 2026, highlighted by higher prescriptions, accelerating revenue growth, and continued gross margin expansion as the company scales its wearable cardioverter defibrillator (WCD) business a
KESTRA MEDICAL TECHNOLOGIES, LTD. Q3 2026 Earnings Call Summary
Moby summary of KESTRA MEDICAL TECHNOLOGIES, LTD.'s Q3 2026 earnings call
Kestra Medical Technologies Ltd (KMTS) Q3 2026 Earnings Call Highlights: Robust Revenue Growth ...
Kestra Medical Technologies Ltd (KMTS) reports a 63% revenue increase, despite ongoing net losses and strategic investments in market expansion.
Kestra Medical Technologies Ltd (KMTS) Q3 2026: Everything You Need To Know Ahead Of Earnings
This article first appeared on GuruFocus. Kestra Medical Technologies Ltd (NASDAQ:KMTS) is set to release its Q3 2026 earnings on Mar 17, 2026. The consensus estimate for Q3 2026 revenue is $22.86 million, and the earnings are expected to come in at -$0.60 per share.